JERECZEK, BARBARA ALICJA
JERECZEK, BARBARA ALICJA
Dipartimento di Oncologia ed Emato-Oncologia
Predictive Modelling of Service Building and Users Mobility Related Energy Consumption Through Machine Learning and Graph Based Analysis
2026 V. Bellandi, S. Siccardi, M.G. Vincini, F. Mastroleo, G. Marvaso, B.A. Jereczek‐fossa, E. Damiani
Stable or not? unraveling the reliability of radiomic features in 4d-computed tomography in early-stage non-small cell lung cancer
2026 S. Volpe, A. Gaeta, M.G. Vincini, M. Zaffaroni, F. Mastroleo, S. Raimondi, M. Pepa, L.J. Isaksson, M. Cremonesi, D. La Torre, M. Guckenberger, F. Bellerba, R. Orecchia, S. Gandini, B.A. Jereczek-Fossa
Stereotactic Radioablation for Ventricular Tachycardia in Patients Untreatable by Catheter Ablation: Evidence of Efficacy, Safety, and Impact on Coronary Arteries
2026 C. Carbucicchio, M. Schiavone, G. Piperno, M.E. Mancini, F. Cattani, M. Sabatino, A. Ferrari, A. Bonomi, F. Marchetti, L. Bianchini, E. Rondi, E. Ventura, S. Mushtaq, V. Catto, R. Orecchia, G. Pompilio, C. Tondo, G. Pontone, B.A. Jereczek-Fossa
Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates?
2025 S. Volpe, M.G. Vincini, M. Zaffaroni, A. Gaeta, S. Raimondi, G. Piperno, J. Franzetti, F. Colombo, A.M. Camarda, F. Mastroleo, F. Botta, L. Spaggiari, S. Gandini, M. Guckenberger, R. Orecchia, M. Casiraghi, B.A. Jereczek-Fossa
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer
2025 M. Milano, C. Valenza, A. Ferrari, S. Gandini, D. Trapani, C. Santoro, E. Battaiotto, A. Carnevale Schianca, E. Giordano, J. Katrini, G. Castellano, B. Taurelli Salimbeni, M.C. Leonardi, S. Dicuonzo, C. Criscitiello, N. Bianco, S. Dellapasqua, E. Munzone, G. Curigliano, M. Colleoni, B.A. Jereczek-Fossa
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy
2025 F. Mastroleo, R. Villa, M. Zaffaroni, M.G. Vincini, C. Franzese, L. Nicosia, F. Matrone, A. Donofrio, A. Magli, L. Triggiani, S. Barra, G. Timon, M. Augugliaro, V. Burgio, G. Francolini, M. Hasterok, M. Miszczyk, N. Simoni, C. Spatola, F. Alongi, S. Arcangeli, M. Scorsetti, G. Marvaso, B.A. Jereczek-Fossa
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study
2025 F. Mastroleo, R. Villa, M. Zaffaroni, M.G. Vincini, C. Franzese, L. Nicosia, F. Matrone, A. Donofrio, A. Magli, L. Triggiani, S. Barra, G. Timon, M. Augugliaro, V. Burgio, G. Francolini, M. Hasterok, M. Miszczyk, N. Simoni, C. Spatola, F. Alongi, S. Arcangeli, M. Scorsetti, G. Marvaso, B.A. Jereczek-Fossa
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025 G. Marvaso, G. Corrao, M. Zaffaroni, M.G. Vincini, C. Lorubbio, S. Gandini, C. Fodor, S. Netti, D. Zerini, S. Luzzago, F.A. Mistretta, K. Venetis, G. Cursano, T. Burla, K. Mazzocco, F. Cattani, G. Petralia, N. Fusco, G. Pravettoni, G. Musi, O. De Cobelli, C. Tang, P. Ost, D.A. Palma, R. Orecchia, B.A. Jereczek-Fossa
Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis
2025 O. Mohamad, L. Mose, M. Ahmadsei, R. Kouzy, C. Zamboglou, L. Nicosia, F. Alongi, T. Zilli, S. Arcangeli, G. Marvaso, B.A. Jereczek-Fossa, M. Guckenberger, D.M. Aebersold, M. Shelan
Coronary artery calcium and cardiovascular risk factors analysis after radiotherapy for breast cancer (the CLARIFIER: a gender-based preventive medicine study)
2025 D. Trabattoni, M.C. Leonardi, M.E. Mancini, B.A. Jereczek-Fossa, F. Cattani, G. Santagostino Baldi, A. Bonomi, A. Galotta, S. Mushtaq, A. Annoni, D. Alio, M.G. Vincini, C.I. Fodor, L. La Grutta, P. Montorsi, G. Pontone
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
2025 V. Murthy, G. Marvaso, B.A. Jereczek-Fossa, S.A. Thoma, M. Vogel, N.-. Schmidt-Hegemann, M. Shelan, S. Siva, T. Hoelscher, A.U. Kishan, J.C. Peeken, S. Gillessen, M. Guckenberger, K. Herrmann, W.P. Fendler, T. Zilli, S.K.B. Spohn, C. Zamboglou
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity
2025 M. Bilski, F. Mastroleo, L. Kuncman, P. Rogowski, S. Durante, C. Putzu, A. Chyrek, G. Marvaso, B. Fionda, L. Tagliaferii, J. Fijuth, A. Vavassori, R. Tolakanahalli, B.A. Jereczek-Fossa, R. Kotecha
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
2025 G. Francolini, N. Bertini, V. Di Cataldo, P. Garlatti, M. Aquilano, S. Caini, A. Bruni, G. Ingrosso, R.M. D'Angelillo, L. Tagliaferri, M. Augugliaro, L. Triggiani, S. Parisi, G. Timon, F. Arcidiacono, G. Marvaso, B.A. Jereczek-Fossa, A. Lancia, C. Franzese, F. Alongi, G. Simontacchi, D. Greto, P. Bonomo, M. Loi, G. Frosini, L. Burchini, I. Desideri, I. Meattini, R.K. Valicenti, L. Livi
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in Italy
2025 A.E. Guerini, G. Marvaso, S. Tonoli, G. Corrao, M.A. Teriaca, M. Sepulcri, M. Scricciolo, A. Gava, S. Montrone, N. Giaj-Levra, B.N. Chiorda, G. Mantello, F. Fiorica, S. Borghesi, L. Belgioia, A. Caroli, A. Fiorentino, B.A. Jereczek-Fossa, S.M. Magrini, M. Buglione
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia
2025 T. Burla, M. Zaffaroni, G. Marvaso, K. Mazzocco, G. Galli, M.G. Vincini, F. Mastroleo, M. Sarra Fiore, G. Pravettoni, B.A. Jereczek-Fossa
Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer
2025 V. Muller, T. Bachelot, G. Curigliano, E. De Azambuja, J. Furtner, J. Gempt, B.A. Jereczek-Fossa, K.J. Jerzak, E.L. Rhun, C. Palmieri, G. Pravettoni, C. Saura, R. Bartsch
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis
2025 M. Miszczyk, M. Bilski, T. Koi, K. Konat-Baska, A. Suleja, T. Fazekas, A. Matsukawa, I. Tsuboi, R. Schulz, P. Rajwa, E. Laukhtina, M.R. Hassler, G. Marvaso, P. Sargos, P. Ost, G. Ploussard, B. Jereczek-Fossa, M. Roupret, P. Chlosta, P.I. Karakiewicz, M. Babjuk, J.Y.-. Teoh, M. Moschini, P. Gontero, S.F. Shariat
Precision Radiotherapy for Kidney Cancer: A Rising Ally in Multidisciplinary Care
2025 B.A. Jereczek-Fossa, F. Mastroleo, G. Marvaso
Stereotactic body radiotherapy combined with immunotherapy or targeted therapy: a screenshot from Italy on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
2025 G. Corrao, G. Marvaso, M. Zaffaroni, M.G. Vincini, S. Badellino, P. Borghetti, F. Cuccia, M. Federico, G. Montesi, A. Pontoriero, C. Franzese, M. Loi, B.A. Jereczek-Fossa, M. Scorsetti
CT-Based Radiomics Enhance Respiratory Function Analysis for Lung SBRT
2025 A. Porazzi, M. Zaffaroni, V.E. Pierini, M. Giulia Vincini, A. Gaeta, S. Raimondi, L. Berton, L.J. Isaksson, F. Mastroleo, S. Gandini, M. Casiraghi, G. Piperno, L. Spaggiari, J. Guarize, S.M. Donghi, Ł. Kuncman, R. Orecchia, S. Volpe, B.A. Jereczek